|  | 

Annual Scientific Meeting 2012

2:00 – 2:05 pm

Welcome Speech

Prof. James CS Chim, University of Hong Kong, Hong Kong

2:05 – 2:35 pm

Clinical use of Immunoglobulin Heavy/light chains in diagnosis and monitoring of multiple myeloma

Dr. Eric Chan, Queen Mary Hospital, Hong Kong

2:35 – 3:05 pm

Added Value of 11C-acetate PET/CT to 18F-FDG for the diagnosis and Management of Multiple Myeloma

Dr. Garrett Ho, Hong Kong Sanatorium & Hospital, Hong Kong

3:05 – 3:50 pm

Bench to Bedside Translation of Targeted Therapeutics in Multiple Myeloma

Dr. Kenneth C. Anderson, Dana Faber Cancer Institute, USA

3:50 – 4:35 pm

Team Break

4:35 – 5:00 pm

Transplantation in Myeloma

Prof. Huang Xiaojun, Peking University Institute of Hematology, China

5:00 – 5:25 pm

Myeloma in Thailand, the Thai Myeloma Working Group

Dr. Weerasak Nawarawong, Chiang Mai University, Thailand

5:25 – 5:50 pm

Frontline treatment for MM in Taiwan – Targeting on novel agents

Dr. Jeffrey Huang, National Taiwan University, Taiwan

5:50 – 6:15 pm

Early results of Korean observation study of VMP or lenalidomide for relapsed or refractory MM in Korea

Dr. Kihyun Kim, Samsung Medical Center, Korea

6:15 – 6:55 pm

European Perspectives on Frontline Multiple Myeloma Treatment

Prof. Mario Boccadoro, Universita degli Studi di Torino, Italy

6:55pm – 7:10 pm

Combined Q&A for Session II

7:10pm – 7:15 pm

Closing Remark

Prof. James CS Chim, University of Hong Kong, Hong Kong



KC Anderson
Dana Faber Cancer Insitiute, Harvard University
Eric Chan
Queen Mary Hospital
Garrett Ho
Hong Kong Sanatorium
Huang Xiaojun
Peking University
Jeffrey Huang
National Taiwan University
Kihyun Kim
Samsung University
Weerasak Nawarawong
Thai Society of Myeloma